Cahaba Wealth Management Inc. Sells 240 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Cahaba Wealth Management Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 4.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,476 shares of the company’s stock after selling 240 shares during the quarter. Cahaba Wealth Management Inc.’s holdings in HCA Healthcare were worth $1,482,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in HCA. RB Capital Management LLC boosted its holdings in HCA Healthcare by 25.9% in the first quarter. RB Capital Management LLC now owns 2,432 shares of the company’s stock valued at $610,000 after acquiring an additional 501 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of HCA Healthcare by 18.6% during the 1st quarter. American Century Companies Inc. now owns 11,035 shares of the company’s stock worth $2,766,000 after buying an additional 1,730 shares in the last quarter. Prudential PLC bought a new position in shares of HCA Healthcare during the 1st quarter worth approximately $1,083,000. Cetera Investment Advisers boosted its holdings in shares of HCA Healthcare by 1.3% during the 1st quarter. Cetera Investment Advisers now owns 4,499 shares of the company’s stock worth $1,128,000 after buying an additional 56 shares in the last quarter. Finally, Sequoia Financial Advisors LLC bought a new position in shares of HCA Healthcare during the 1st quarter worth approximately $248,000. 62.73% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have issued reports on HCA. Oppenheimer restated an “outperform” rating and set a $315.00 price target on shares of HCA Healthcare in a report on Wednesday, January 17th. Barclays assumed coverage on HCA Healthcare in a report on Wednesday, March 6th. They issued an “overweight” rating and a $356.00 target price on the stock. Cantor Fitzgerald restated an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research note on Tuesday, March 5th. Raymond James raised their price objective on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Finally, Sanford C. Bernstein lowered HCA Healthcare from an “outperform” rating to a “market perform” rating and raised their target price for the company from $277.00 to $301.00 in a research report on Thursday, January 4th. Four equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $311.47.

Get Our Latest Stock Analysis on HCA Healthcare

HCA Healthcare Price Performance

HCA stock traded down $0.76 during mid-day trading on Tuesday, reaching $329.35. 904,576 shares of the company traded hands, compared to its average volume of 1,082,828. The company has a debt-to-equity ratio of 35.07, a current ratio of 1.18 and a quick ratio of 1.02. The company has a market capitalization of $87.11 billion, a P/E ratio of 17.35, a P/E/G ratio of 1.67 and a beta of 1.65. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $334.49. The company has a fifty day moving average price of $313.78 and a 200-day moving average price of $274.88.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, beating analysts’ consensus estimates of $5.05 by $0.85. The business had revenue of $17.30 billion during the quarter, compared to analyst estimates of $16.51 billion. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The company’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.64 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 20.49 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were given a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.80%. The ex-dividend date was Thursday, March 14th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.60. HCA Healthcare’s dividend payout ratio (DPR) is 13.91%.

HCA Healthcare announced that its board has approved a stock buyback program on Tuesday, January 30th that authorizes the company to repurchase $6.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 7.4% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

Insider Activity

In related news, SVP Chad J. Wasserman sold 652 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $312.04, for a total value of $203,450.08. Following the completion of the sale, the senior vice president now owns 290 shares in the company, valued at approximately $90,491.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Sammie S. Mosier sold 1,645 shares of the business’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $312.00, for a total transaction of $513,240.00. Following the transaction, the senior vice president now directly owns 7,646 shares of the company’s stock, valued at $2,385,552. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Chad J. Wasserman sold 652 shares of the company’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $312.04, for a total value of $203,450.08. Following the completion of the sale, the senior vice president now directly owns 290 shares in the company, valued at $90,491.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 14,840 shares of company stock worth $4,588,869. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.